Results 231 to 240 of about 216,511 (353)
Abstract Objectives Primary intestinal lymphangiectasia (PIL) is a very rare disease responsible for protein‐losing enteropathy. There is little published data about treatments efficacy and outcomes. Our main objective was to describe the clinical profile, response to therapy, and outcomes of children with PIL.
Noémie Goret +12 more
wiley +1 more source
Visceral fat lipolysis by pancreatic lipases worsens heart failure. [PDF]
Smichi N +13 more
europepmc +1 more source
Abstract Children with inflammatory bowel diseases (IBD) have limited access to the available advanced therapies, given the lengthy gap between adult and pediatric approval. We aimed to review key hurdles for pediatric trials and recommend practical solutions.
Dan Turner +21 more
wiley +1 more source
Editorial Comment on "The Impact of Visceral Fat Accumulation on 24-h Urine Chemistries and Stone-Recurrence in Patients With Urolithiasis". [PDF]
Matsuo T, Imamura R.
europepmc +1 more source
The obesity-induced transcriptional regulator TRIP-Br2 mediates visceral fat endoplasmic reticulum stress-induced inflammation [PDF]
Guifen Qiang +8 more
openalex +1 more source
Abstract Objective Extensively hydrolyzed formulas (eHF) are the first‐line approach for cow's milk protein allergy (CMPA). This study evaluated the effects of eHF with synbiotic eHF (SeHF) on the general condition and symptoms of presumed CMPA infants during the initial 4‐week exclusion diet period.
Anaïs Lemoine +3 more
wiley +1 more source
Association of metabolic score for visceral fat (METS-VF) with lumbar spine bone mineral density in US adults. [PDF]
Dong H +5 more
europepmc +1 more source
Abstract Objectives Pediatric intestinal pseudo‐obstruction (PIPO) is a severe bowel motility disorder characterized by impaired propulsion of gastrointestinal contents without mechanical obstruction. PIPO encompasses congenital and acquired disorders, including neuropathies, myopathies, and mesenchymopathies.
Sharon Wolfson +8 more
wiley +1 more source

